09/07/2020 | Sponsored by Santen Pharmaceuticals
Ophthalmology is now ready to embrace gene therapy technologies that promise a stream of novel products for unmet medical needs
09/01/2020 | Julia A. Haller
How Wills Eye Hospital is weathering the pandemic storm
08/26/2020
Delayed presentation, longer distances to treatment centers, less insurance coverage – our patients face a host of new challenges in a pandemic
08/25/2020 | Reza Razeghinejad, Aakriti G. Shukla
How does a novel portable head-mounted perimeter compare with the gold standard in visual field testing?
08/25/2020 | Phoebe Harkin
Developing a nomogram to predict graft survival after penetrating keratoplasty
08/24/2020 | Phoebe Harkin
Three papers, one purpose: to save patients from melanoma-related metastasis
08/20/2020 | Phoebe Harkin
Clinical trials make the case for gene therapy injections in LHON patients
08/19/2020
Sitting Down With… Jose Pulido, Larry A. Donoso Endowed Chair, Wills Eye
08/17/2020 | Jonathan Myers
In an era of improved technologies, it has never been easier – or more affordable – to identify undiagnosed glaucoma patients
08/15/2020
Establishing an accurate, understandable classification system for conjunctival epithelial pigmentations
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
Redressing Representation
Living with TED: My Race from Patient to Advocate
How Dry Eye Disease Impacts Younger Patients
The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: